Literature DB >> 16403522

R-state haemoglobin with low oxygen affinity: crystal structures of deoxy human and carbonmonoxy horse haemoglobin bound to the effector molecule L35.

Takeshi Yokoyama1, Saburo Neya, Antonio Tsuneshige, Takashi Yonetani, Sam-Yong Park, Jeremy R H Tame.   

Abstract

Although detailed crystal structures of haemoglobin (Hb) provide a clear understanding of the basic allosteric mechanism of the protein, and how this in turn controls oxygen affinity, recent experiments with artificial effector molecules have shown a far greater control of oxygen binding than with natural heterotropic effectors. Contrary to the established text-book view, these non-physiological compounds are able to reduce oxygen affinity very strongly without switching the protein to the T (tense) state. In an earlier paper we showed that bezafibrate (BZF) binds to a surface pocket on the alpha subunits of R state Hb, strongly reducing the oxygen affinity of this protein conformation. Here we report the crystallisation of Hb with L35, a related compound, and show that this binds to the central cavity of both R and T state Hb. The mechanism by which L35 reduces oxygen affinity is discussed, in relation to spectroscopic studies of effector binding.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16403522     DOI: 10.1016/j.jmb.2005.12.018

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

1.  Circular dichroism spectroscopy of tertiary and quaternary conformations of human hemoglobin entrapped in wet silica gels.

Authors:  Luca Ronda; Stefano Bruno; Cristiano Viappiani; Stefania Abbruzzetti; Andrea Mozzarelli; Kenneth C Lowe; Stefano Bettati
Journal:  Protein Sci       Date:  2006-07-05       Impact factor: 6.725

Review 2.  Protein dynamics explain the allosteric behaviors of hemoglobin.

Authors:  Takashi Yonetani; Monique Laberge
Journal:  Biochim Biophys Acta       Date:  2008-05-08

3.  Molecular mechanism of photoactivation of a light-regulated adenylate cyclase.

Authors:  Mio Ohki; Ayana Sato-Tomita; Shigeru Matsunaga; Mineo Iseki; Jeremy R H Tame; Naoya Shibayama; Sam-Yong Park
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

4.  Identification of a novel class of covalent modifiers of hemoglobin as potential antisickling agents.

Authors:  A M Omar; M A Mahran; M S Ghatge; N Chowdhury; F H A Bamane; M E El-Araby; O Abdulmalik; M K Safo
Journal:  Org Biomol Chem       Date:  2015-06-14       Impact factor: 3.876

5.  Solution structure and dynamics of human hemoglobin in the carbonmonoxy form.

Authors:  Jing-Song Fan; Yu Zheng; Wing-Yiu Choy; Virgil Simplaceanu; Nancy T Ho; Chien Ho; Daiwen Yang
Journal:  Biochemistry       Date:  2013-08-15       Impact factor: 3.162

6.  Ameliorative effects of quercetin against bisphenol A-caused oxidative stress in human erythrocytes: an in vitro and in silico study.

Authors:  Neha P Sangai; Chirag N Patel; Himanshu A Pandya
Journal:  Toxicol Res (Camb)       Date:  2018-08-22       Impact factor: 3.524

7.  Methemoglobinemia caused by 8-aminoquinoline drugs: DFT calculations suggest an analogy to H4B's role in nitric oxide synthase.

Authors:  Haining Liu; Larry A Walker; N P Dhammika Nanayakkara; Robert J Doerksen
Journal:  J Am Chem Soc       Date:  2011-01-18       Impact factor: 15.419

8.  Structure of the altitude adapted hemoglobin of guinea pig in the R2-state.

Authors:  Bruno Pairet; Elmar Jaenicke
Journal:  PLoS One       Date:  2010-08-24       Impact factor: 3.240

9.  Molecular dynamics simulations of hemoglobin A in different states and bound to DPG: effector-linked perturbation of tertiary conformations and HbA concerted dynamics.

Authors:  Monique Laberge; Takashi Yonetani
Journal:  Biophys J       Date:  2007-12-20       Impact factor: 4.033

10.  NO reactions with sol-gel and solution phase samples of the ferric nitrite derivative of HbA.

Authors:  Camille J Roche; Joel M Friedman
Journal:  Nitric Oxide       Date:  2009-11-15       Impact factor: 4.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.